MA26831A1 - Derives de benzodiazepine." - Google Patents

Derives de benzodiazepine."

Info

Publication number: MA26831A1
Authority: MA; Morocco
Prior art keywords: benzodiazepine derivatives; benzodiazepine; derivatives
Prior art date: 1999-10-15

Application number

MA26601A

Other languages

English (en)

Inventor

Geo Adam

Erwin Goetschi

Thomas Johannes Woltering

Alexander Alanine

Vincent Mutel

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-15

Filing date

2002-04-15

Publication date

2004-12-20

2002-04-15 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26831A1 publication Critical patent/MA26831A1/fr

Links

229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title 1
150000001557 benzodiazepines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA26601A 1999-10-15 2002-04-15 Derives de benzodiazepine." MA26831A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99120520		1999-10-15

Publications (1)

Publication Number	Publication Date
MA26831A1 true MA26831A1 (fr)	2004-12-20

Family

ID=8239207

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26601A MA26831A1 (fr)	1999-10-15	2002-04-15	Derives de benzodiazepine."

Country Status (34)

Country	Link
US (1)	US6407094B1 (fr)
EP (1)	EP1224174B1 (fr)
JP (1)	JP3857138B2 (fr)
KR (1)	KR100480320B1 (fr)
CN (1)	CN1195522C (fr)
AR (1)	AR026029A1 (fr)
AT (1)	ATE250039T1 (fr)
AU (1)	AU774451B2 (fr)
BR (1)	BR0014859A (fr)
CA (1)	CA2386974C (fr)
CO (1)	CO5261604A1 (fr)
CZ (1)	CZ20021653A3 (fr)
DE (1)	DE60005386T2 (fr)
DK (1)	DK1224174T3 (fr)
EG (1)	EG24079A (fr)
ES (1)	ES2204704T3 (fr)
GC (1)	GC0000263A (fr)
HR (1)	HRP20020259A2 (fr)
HU (1)	HUP0203142A3 (fr)
IL (2)	IL148816A0 (fr)
JO (1)	JO2262B1 (fr)
MA (1)	MA26831A1 (fr)
MY (1)	MY125540A (fr)
NO (1)	NO327817B1 (fr)
NZ (1)	NZ517999A (fr)
PE (1)	PE20010681A1 (fr)
PL (1)	PL357418A1 (fr)
PT (1)	PT1224174E (fr)
RU (1)	RU2259360C2 (fr)
SI (1)	SI1224174T1 (fr)
TR (1)	TR200201023T2 (fr)
WO (1)	WO2001029011A2 (fr)
YU (1)	YU26202A (fr)
ZA (1)	ZA200202544B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE261945T1 (de)	1999-10-15	2004-04-15	Hoffmann La Roche	Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
CA2442557C (fr)	2001-04-12	2008-12-23	F. Hoffmann-La Roche Ag	Derives dihydro-benzo¬b\|¬1,4\|diazepin-2-one utilises comme antagonistes de mglur2(ii)
NZ528345A (en)	2001-04-12	2005-04-29	F	Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mGluR2 antagonists I
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US6949542B2 (en) *	2002-02-06	2005-09-27	Hoffman-La Roche Inc.	Dihydro-benzo[b][1,4]diazepin-2-one derivatives
US8354447B2 (en) *	2002-09-10	2013-01-15	The Scripps Research Institute	mGLU receptors antagonists for treating disorders associated with mGLU receptors including addiction and depression
ATE510174T1 (de)	2003-05-21	2011-06-15	Alexza Pharmaceuticals Inc	Schlag gezündete unabhängige heizeinheit
ATE374030T1 (de) *	2003-07-25	2007-10-15	Hoffmann La Roche	Kombination eines mglur2 antagonists und eines ache inhibitors zur behandlung von akuten und/oder chronischen neurologischen krankheiten
FR2862969A1 (fr) *	2003-11-28	2005-06-03	Oreal	Procede de preparation de derives paraphenylenediamine a groupement pyrrolidinyle, substitue par un radical azote, et composes intermediaires
DE102004010893A1 (de) *	2004-03-06	2005-09-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en)	2004-08-12	2011-04-14	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heat packages
ATE400557T1 (de)	2004-11-05	2008-07-15	Hoffmann La Roche	Verfahren zur herstellung von isonikotinsäurederivaten
AP2007004047A0 (en)	2005-01-20	2007-06-30	Pfizer Ltd	Substituted triazole derivatives as oxtocin antagonists
AR059898A1 (es)	2006-03-15	2008-05-07	Janssen Pharmaceutica Nv	Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
US20080216828A1 (en)	2007-03-09	2008-09-11	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
BRPI0810655A2 (pt)	2007-04-19	2014-11-04	Hoffmann La Roche	Derivados de di-hidro-benzo[b][1,4] diazepin-2-ona sulfonamida
SI2203439T1 (sl)	2007-09-14	2011-05-31	Ortho Mcneil Janssen Pharm	1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
BRPI0817101A2 (pt)	2007-09-14	2017-05-09	Addex Pharmaceuticals Sa	4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
ES2409215T3 (es) *	2007-09-14	2013-06-25	Janssen Pharmaceuticals, Inc.	4-fenil-1H-piridin-2-onas 1-3-disustituidas
UA99308C2 (ru) *	2007-09-26	2012-08-10	Маунт Синай Скул Оф Медсин	Аналог азацитидина и его применение
ES2637794T3 (es) *	2007-11-14	2017-10-17	Janssen Pharmaceuticals, Inc.	Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
ES2439291T3 (es)	2008-09-02	2014-01-22	Janssen Pharmaceuticals, Inc.	Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
CA2738849C (fr)	2008-10-16	2016-06-28	Addex Pharma S.A.	Derives d'indole et de benzomorpholine en tant que modulateurs des recepteurs metabotropiques du glutamate
ES2401691T3 (es)	2008-11-28	2013-04-23	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato
ES2440001T3 (es)	2009-05-12	2014-01-27	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-A]piridina y su uso para el tratamiento o prevención de trastornos neurológicos y psiquiátricos
SG176018A1 (en)	2009-05-12	2011-12-29	Janssen Pharmaceuticals Inc	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN101891706B (zh) *	2010-04-09	2013-05-29	复旦大学	3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
US8642626B2 (en)	2010-07-29	2014-02-04	Taisho Pharmaceutical Co., Ltd.	Ethinyl-pyrazole derivative
CA2814998C (fr)	2010-11-08	2019-10-29	Janssen Pharmaceuticals, Inc.	Derives de 1,2,4-triazolo[4,3-a]pyridine et leur utilisation en tant que modulateurs allosteriques positifs des recepteurs mglur2
ES2552455T3 (es)	2010-11-08	2015-11-30	Janssen Pharmaceuticals, Inc.	Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
CN103298809B (zh)	2010-11-08	2016-08-31	杨森制药公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JP2012153674A (ja) *	2011-01-28	2012-08-16	Astellas Pharma Inc	ジ（アリールアミノ）アリール化合物の製造方法及びその合成中間体
KR20150070187A (ko)	2012-10-23	2015-06-24	에프. 호프만-라 로슈 아게	자폐 장애의 치료를 위한 ｍｇｌｕ２／３ 길항제
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
IL279202B2 (en)	2014-01-21	2023-09-01	Janssen Pharmaceutica Nv	Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
US10537573B2 (en)	2014-01-21	2020-01-21	Janssen Pharmaceutica Nv	Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
US9895324B2 (en)	2014-03-26	2018-02-20	University Of Kentucky Research Foundation	Halogenated diarylacetylenes and methods of treating cancer
KR20160143853A (ko)	2014-04-23	2016-12-14	에프. 호프만-라 로슈 아게	지적 장애의 치료를 위한 mglu2/3 길항제
WO2015191630A1 (fr)	2014-06-10	2015-12-17	Sanford-Burnham Medical Research Institute	Modulateurs allostériques négatifs (nam) du récepteur métabotropique du glutamate et utilisations de ceux-ci
CN106243050B (zh) *	2016-08-10	2019-09-06	安徽恒星制药有限公司	一种适合工业化生产氯巴占的方法
CN109836356B (zh) *	2017-11-24	2022-03-08	沈阳化工研究院有限公司	一种芳甲醚衍生物及其应用
US12214118B2 (en)	2018-02-02	2025-02-04	Alexza Pharmaceuticals, Inc.	Electrical condensation aerosol device
RU2702358C1 (ru) *	2019-06-04	2019-10-08	Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук	Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов
CN114349779B (zh) *	2021-12-29	2023-09-26	智仑超纯环氧树脂(西安)有限公司	一种改性二氧化硅颗粒除氯剂及其制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU437924A1 (ru) *	1972-07-28	1974-07-30	Институт Горного Дела Ан Казахской Сср	Цифровой автоматический измеритель скорости распространени упругих волн
SU749836A1 (ru) *	1978-02-13	1980-07-23	Днепропетровский Ордена Трудового Красного Знамени Государственный Университет Им. 300-Летия Воссоединения Украины С Россией	Способ получени 4-метил2,3-дигидро1н-1,5-бензодиазепинонов-2
WO1997005109A1 (fr) *	1995-07-31	1997-02-13	Novo Nordisk A/S	Composes heterocycliques, leur preparation et utilisation
IL136250A0 (en) *	1997-11-21	2001-05-20	Nps Pharma Inc	Metabotropic glutamate receptor antagonist compounds

2000
- 2000-09-29 AT AT00969347T patent/ATE250039T1/de not_active IP Right Cessation
- 2000-09-29 IL IL14881600A patent/IL148816A0/xx active IP Right Grant
- 2000-09-29 BR BR0014859-8A patent/BR0014859A/pt not_active Application Discontinuation
- 2000-09-29 ES ES00969347T patent/ES2204704T3/es not_active Expired - Lifetime
- 2000-09-29 PL PL00357418A patent/PL357418A1/xx unknown
- 2000-09-29 PT PT00969347T patent/PT1224174E/pt unknown
- 2000-09-29 EP EP00969347A patent/EP1224174B1/fr not_active Expired - Lifetime
- 2000-09-29 TR TR2002/01023T patent/TR200201023T2/xx unknown
- 2000-09-29 CA CA002386974A patent/CA2386974C/fr not_active Expired - Fee Related
- 2000-09-29 WO PCT/EP2000/009553 patent/WO2001029011A2/fr not_active Ceased
- 2000-09-29 HU HU0203142A patent/HUP0203142A3/hu unknown
- 2000-09-29 DK DK00969347T patent/DK1224174T3/da active
- 2000-09-29 NZ NZ517999A patent/NZ517999A/en unknown
- 2000-09-29 YU YU26202A patent/YU26202A/sh unknown
- 2000-09-29 HR HR20020259A patent/HRP20020259A2/xx not_active Application Discontinuation
- 2000-09-29 CZ CZ20021653A patent/CZ20021653A3/cs unknown
- 2000-09-29 CN CNB008142742A patent/CN1195522C/zh not_active Expired - Fee Related
- 2000-09-29 RU RU2002110104/04A patent/RU2259360C2/ru not_active IP Right Cessation
- 2000-09-29 AU AU79102/00A patent/AU774451B2/en not_active Ceased
- 2000-09-29 KR KR10-2002-7004838A patent/KR100480320B1/ko not_active Expired - Fee Related
- 2000-09-29 SI SI200030210T patent/SI1224174T1/xx unknown
- 2000-09-29 JP JP2001531811A patent/JP3857138B2/ja not_active Expired - Fee Related
- 2000-09-29 DE DE60005386T patent/DE60005386T2/de not_active Expired - Lifetime
- 2000-10-10 JO JO2000169A patent/JO2262B1/en active
- 2000-10-10 PE PE2000001083A patent/PE20010681A1/es not_active Application Discontinuation
- 2000-10-11 GC GCP2000950 patent/GC0000263A/en active
- 2000-10-12 CO CO00077957A patent/CO5261604A1/es not_active Application Discontinuation
- 2000-10-13 AR ARP000105386A patent/AR026029A1/es unknown
- 2000-10-13 US US09/687,240 patent/US6407094B1/en not_active Expired - Fee Related
- 2000-10-13 MY MYPI20004817A patent/MY125540A/en unknown
- 2000-10-14 EG EG20001310A patent/EG24079A/xx active
2002
- 2002-03-21 IL IL148816A patent/IL148816A/en not_active IP Right Cessation
- 2002-03-28 ZA ZA200202544A patent/ZA200202544B/xx unknown
- 2002-04-10 NO NO20021690A patent/NO327817B1/no not_active IP Right Cessation
- 2002-04-15 MA MA26601A patent/MA26831A1/fr unknown

Also Published As

Publication number	Publication date
KR20020038954A (ko)	2002-05-24
HK1051038A1 (en)	2003-07-18
JP3857138B2 (ja)	2006-12-13
PT1224174E (pt)	2004-01-30
YU26202A (sh)	2004-12-31
HUP0203142A3 (en)	2003-03-28
BR0014859A (pt)	2002-07-16
GC0000263A (en)	2006-11-01
CO5261604A1 (es)	2003-03-31
NO20021690D0 (no)	2002-04-10
IL148816A0 (en)	2002-09-12
NO327817B1 (no)	2009-09-28
KR100480320B1 (ko)	2005-04-07
PE20010681A1 (es)	2001-06-28
DE60005386D1 (de)	2003-10-23
AU774451B2 (en)	2004-06-24
HRP20020259A2 (en)	2004-04-30
EG24079A (en)	2008-05-11
ES2204704T3 (es)	2004-05-01
ATE250039T1 (de)	2003-10-15
CA2386974C (fr)	2009-10-13
EP1224174B1 (fr)	2003-09-17
CA2386974A1 (fr)	2001-04-26
RU2259360C2 (ru)	2005-08-27
CZ20021653A3 (cs)	2002-08-14
MY125540A (en)	2006-08-30
CN1379765A (zh)	2002-11-13
AR026029A1 (es)	2002-12-26
TR200201023T2 (tr)	2002-09-23
PL357418A1 (en)	2004-07-26
HUP0203142A2 (hu)	2003-02-28
JP2003512359A (ja)	2003-04-02
JO2262B1 (en)	2004-10-07
WO2001029011A2 (fr)	2001-04-26
EP1224174A2 (fr)	2002-07-24
CN1195522C (zh)	2005-04-06
DE60005386T2 (de)	2004-06-24
NZ517999A (en)	2004-07-30
NO20021690L (no)	2002-04-10
AU7910200A (en)	2001-04-30
IL148816A (en)	2006-10-31
US6407094B1 (en)	2002-06-18
WO2001029011A3 (fr)	2001-11-08
ZA200202544B (en)	2003-09-23
SI1224174T1 (en)	2003-12-31
DK1224174T3 (da)	2004-01-26

Publication	Publication Date	Title
MA26831A1 (fr)	2004-12-20	Derives de benzodiazepine."
MA26832A1 (fr)	2004-12-20	Derives de benzodiazepine.
MA26816A1 (fr)	2004-12-20	Derives d'amino-triazolopyridine
ATE435861T1 (de)	2009-07-15	12,13-cyclopropan-epothilonderivate
PT1218378E (pt)	2003-09-30	Derivados de terc-butil-(7-metil-imidazo-¬1,2-a\|-piridin-3-il)-amina
MA26504A1 (fr)	2004-12-20	Derives benzimidazole.
TR200000520A3 (tr)	2001-06-21	4-Fenil-piridin türevleri.
PT901474E (pt)	2006-07-31	Derivados de aril-pirimidina.
DK1000048T3 (da)	2003-03-03	Substituerede 1,2,3,4-tetrahydronapthalenderivater
MA26794A1 (fr)	2004-12-20	Derives de 5-phenyl-pyrimidine.
MA26503A1 (fr)	2004-12-20	Derives de 5'-desoxy-cytidine.
PT921125E (pt)	2002-06-28	Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
PT1154988E (pt)	2004-12-31	Derivados de mevinolina
MA26793A1 (fr)	2004-12-20	Derives de 4-phenyl-pyrimidine.
MA23504A1 (fr)	1995-12-31	Derives de la 1,5 benzodiazepine
EE200000447A (et)	2001-12-17	1,3,4-oksadiasolooni derivaadid
DE60025958D1 (de)	2006-04-20	14,15-beta-methylen substituierte androgene
EP1046648A4 (fr)	2002-09-11	Derives de 3'-desoxyribonucleotide
PT1088818E (pt)	2005-03-31	Derivados de quinolin-4-ilo
MA26480A1 (fr)	2004-12-20	Derives de phenoxymethylpiperidine
PT1060183E (pt)	2003-08-29	Derivados de 5'-desoxicitidina
PT1129079E (pt)	2006-05-31	Derivados de triazina 2,4-dissubstituidos
NO20015397D0 (no)	2001-11-05	1,5-Benzodiazepin-derivater
ATE243218T1 (de)	2003-07-15	2''-deoxyhygromycinderivate
EP1240156A4 (fr)	2003-04-16	Derives de 3-methyl-chromane ou de thiochromane